Cargando…

Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia

OBJECTIVES: There are only a limited number of studies on cyclin D1 and p63 expression in oral squamous cell carcinoma (OSCC) and leukoplakia. This study compared cyclin D1 and p63 expression in leukoplakia and OSCC to investigate the possible correlation of both markers with grade of dysplasia and...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sunit B., Manjunatha, Bhari S., Shah, Vandana, Soni, Nishit, Sutariya, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Oral and Maxillofacial Surgeons 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685862/
https://www.ncbi.nlm.nih.gov/pubmed/29142867
http://dx.doi.org/10.5125/jkaoms.2017.43.5.324
_version_ 1783278693097930752
author Patel, Sunit B.
Manjunatha, Bhari S.
Shah, Vandana
Soni, Nishit
Sutariya, Rakesh
author_facet Patel, Sunit B.
Manjunatha, Bhari S.
Shah, Vandana
Soni, Nishit
Sutariya, Rakesh
author_sort Patel, Sunit B.
collection PubMed
description OBJECTIVES: There are only a limited number of studies on cyclin D1 and p63 expression in oral squamous cell carcinoma (OSCC) and leukoplakia. This study compared cyclin D1 and p63 expression in leukoplakia and OSCC to investigate the possible correlation of both markers with grade of dysplasia and histological grade of OSCC. MATERIALS AND METHODS: The study included a total of 60 cases, of which 30 were diagnosed with OSCC and 30 with leukoplakia, that were evaluated immunohistochemically for p63 and cyclin D1 expression. Protein expression was correlated based on grades of dysplasia and OSCC. RESULTS: Out of 30 cases of OSCC, 23 cases (76.7%) were cyclin D1 positive and 30 cases (100%) were p63 positive. Out of 30 cases of leukoplakia, 21 cases (70.0%) were cyclin D1 positive and 30 (100%) were p63 positive (P<0.05). CONCLUSION: The overall expression of cyclin D1 and p63 correlated with tumor differentiation, and increases were correlated with poor histological grades, from well-differentiated to poorly-differentiated SCC. Increased cyclin D1 and p63 expression was associated with the severity of leukoplakia. Based on these results cyclin D1 and p63 products can be a useful tool for improved leukoplakia prognosis.
format Online
Article
Text
id pubmed-5685862
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Association of Oral and Maxillofacial Surgeons
record_format MEDLINE/PubMed
spelling pubmed-56858622017-11-15 Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia Patel, Sunit B. Manjunatha, Bhari S. Shah, Vandana Soni, Nishit Sutariya, Rakesh J Korean Assoc Oral Maxillofac Surg Original Article OBJECTIVES: There are only a limited number of studies on cyclin D1 and p63 expression in oral squamous cell carcinoma (OSCC) and leukoplakia. This study compared cyclin D1 and p63 expression in leukoplakia and OSCC to investigate the possible correlation of both markers with grade of dysplasia and histological grade of OSCC. MATERIALS AND METHODS: The study included a total of 60 cases, of which 30 were diagnosed with OSCC and 30 with leukoplakia, that were evaluated immunohistochemically for p63 and cyclin D1 expression. Protein expression was correlated based on grades of dysplasia and OSCC. RESULTS: Out of 30 cases of OSCC, 23 cases (76.7%) were cyclin D1 positive and 30 cases (100%) were p63 positive. Out of 30 cases of leukoplakia, 21 cases (70.0%) were cyclin D1 positive and 30 (100%) were p63 positive (P<0.05). CONCLUSION: The overall expression of cyclin D1 and p63 correlated with tumor differentiation, and increases were correlated with poor histological grades, from well-differentiated to poorly-differentiated SCC. Increased cyclin D1 and p63 expression was associated with the severity of leukoplakia. Based on these results cyclin D1 and p63 products can be a useful tool for improved leukoplakia prognosis. The Korean Association of Oral and Maxillofacial Surgeons 2017-10 2017-10-26 /pmc/articles/PMC5685862/ /pubmed/29142867 http://dx.doi.org/10.5125/jkaoms.2017.43.5.324 Text en Copyright © 2017 The Korean Association of Oral and Maxillofacial Surgeons. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Patel, Sunit B.
Manjunatha, Bhari S.
Shah, Vandana
Soni, Nishit
Sutariya, Rakesh
Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia
title Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia
title_full Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia
title_fullStr Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia
title_full_unstemmed Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia
title_short Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia
title_sort immunohistochemical evaluation of p63 and cyclin d1 in oral squamous cell carcinoma and leukoplakia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685862/
https://www.ncbi.nlm.nih.gov/pubmed/29142867
http://dx.doi.org/10.5125/jkaoms.2017.43.5.324
work_keys_str_mv AT patelsunitb immunohistochemicalevaluationofp63andcyclind1inoralsquamouscellcarcinomaandleukoplakia
AT manjunathabharis immunohistochemicalevaluationofp63andcyclind1inoralsquamouscellcarcinomaandleukoplakia
AT shahvandana immunohistochemicalevaluationofp63andcyclind1inoralsquamouscellcarcinomaandleukoplakia
AT soninishit immunohistochemicalevaluationofp63andcyclind1inoralsquamouscellcarcinomaandleukoplakia
AT sutariyarakesh immunohistochemicalevaluationofp63andcyclind1inoralsquamouscellcarcinomaandleukoplakia